Resources
52 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 6/12/2020 (updated 9/2/2021)
Mother & Baby Substance Exposure Toolkit Best Practices All Best Practices came as a part of the California Medication Assisted Treatment Expansion Project
Posted 1/28/2020 (updated 9/2/2021)
In January 2014, the American Society of Addiction Medicine (ASAM) released its Standards of Care for the Addiction Specialist Physician.
Posted 5/22/2020 (updated 9/2/2021)
To identify Finnegan Neonatal Abstinence Scoring Tool tems independently associated with the decision to use pharmacologic therapy and to simplify the FNAST while minimizing loss of information for the treatment decision.
Posted 5/12/2020 (updated 9/2/2021)
The Clinical Opiate Withdrawal Scale is an 11-item scale designed to be administered by a clinician.
Posted 5/12/2020 (updated 9/2/2021)
The CIWA-Ar assessment for monitoring withdrawal symptoms requires approximately 5 minutes to administer. The maximum score is 67. Patients scoring less than 10 do not usually need additional medication for withdrawal.
Posted 6/15/2020 (updated 9/2/2021)
The Opioid Use Disorder, Pregnant Women and Neonatal Abstinence Syndrome (NAS): Addressing the Challenges (Part II) webinar took place on June 9, 2020.
Posted 6/30/2020 (updated 9/2/2021)
This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.
Posted 12/2/2020 (updated 9/2/2021)
This Association of Maternal & Child Health Programs (AMCHP) issue brief discusses the challenges and opportunities in providing rural community care to women with mental health and substance use treatment needs.
Posted 12/15/2020 (updated 9/2/2021)
This workshop presented strategies to integrate HIV, hepatitis, and sexual health concerns into services for PWID. The session focused on communication skills, assessment techniques, and building motivation to make healthier choices. The presentation looked at programmatic and clinical level integration strategies and offered participants a chance to assess current service delivery models and develop a plan to enhance care.
Posted 12/29/2020 (updated 9/2/2021)
Whereas outpatient treatment with medication for opioid use disorder (MOUD) is evidence based, there is a large network of inpatient facilities in the US that are reimbursed by commercial insurers and do not typically offer MOUD. This study is a comparison of rates of overdose and hospitalization after initiation of medication for Opioid Use Disorder in the inpatient vs outpatient setting.